231 related articles for article (PubMed ID: 27496878)
1. Blood capillary rarefaction and lymphatic capillary neoangiogenesis are key contributors to renal allograft fibrosis in an ACE inhibition rat model.
Hamar P; Kerjaschki D
Am J Physiol Heart Circ Physiol; 2016 Oct; 311(4):H981-H990. PubMed ID: 27496878
[TBL] [Abstract][Full Text] [Related]
2. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.
Szabo A; Lutz J; Schleimer K; Antus B; Hamar P; Philipp T; Heemann U
Kidney Int; 2000 Mar; 57(3):982-91. PubMed ID: 10720951
[TBL] [Abstract][Full Text] [Related]
3. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting-enzyme inhibition restores glomerular glycosaminoglycans in rat puromycin nephrosis.
Herman-Edelstein M; Chagnac A; Nevo Z; Skutelsky E; Evron Y; Hirsch Y; Ben-Dor L; Schwartz I; Schwartz D; Weinstein T
Exp Toxicol Pathol; 2016 Nov; 68(10):543-552. PubMed ID: 27591087
[TBL] [Abstract][Full Text] [Related]
5. Candesartan cilexetil reduces chronic renal allograft injury in Fisher-->Lewis rats.
Mackenzie HS; Ziai F; Nagano H; Azuma H; Troy JL; Rennke HG; Tilney NL; Brenner BM
J Hypertens Suppl; 1997 Dec; 15(6):S21-5. PubMed ID: 9493123
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory lymphangiogenesis in a rat transplant model of interstitial fibrosis and tubular atrophy.
Vass DG; Shrestha B; Haylor J; Hughes J; Marson L
Transpl Int; 2012 Jul; 25(7):792-800. PubMed ID: 22533613
[TBL] [Abstract][Full Text] [Related]
7. Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats.
Adamczak M; Gross ML; Krtil J; Koch A; Tyralla K; Amann K; Ritz E
J Am Soc Nephrol; 2003 Nov; 14(11):2833-42. PubMed ID: 14569093
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin converting enzyme inhibition blocks interstitial hyaluronan dissipation in the neonatal rat kidney via hyaluronan synthase 2 and hyaluronidase 1.
Stridh S; Kerjaschki D; Chen Y; Rügheimer L; Astrand AB; Johnsson C; Friberg P; Olerud J; Palm F; Takahashi T; Ikegami-Kawai M; Hansell P
Matrix Biol; 2011 Jan; 30(1):62-9. PubMed ID: 20933085
[TBL] [Abstract][Full Text] [Related]
9. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
Noda M; Fukuda R; Matsuo T; Ohta M; Nagano H; Imura Y; Nishikawa K; Shibouta Y
Kidney Int Suppl; 1997 Dec; 63():S136-9. PubMed ID: 9407442
[TBL] [Abstract][Full Text] [Related]
10. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition.
Diamond JR; Anderson S
Am J Pathol; 1990 Dec; 137(6):1323-32. PubMed ID: 2260622
[TBL] [Abstract][Full Text] [Related]
11. Effects of treatment with angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (AIIRA) on renal function and glomerular injury in subtotal nephrectomized rats.
Yamamoto M; Fukui M; Shou I; Wang LN; Sekizuka K; Suzuki S; Shirato I; Tomino Y
J Clin Lab Anal; 1997; 11(1):53-62. PubMed ID: 9021525
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin inhibition in the developing kidney; tubulointerstitial effect.
Yoo KH; Yim HE; Bae ES; Hong YS
Pediatr Res; 2019 Apr; 85(5):724-730. PubMed ID: 30700837
[TBL] [Abstract][Full Text] [Related]
13. Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats.
Yazdani S; Hijmans RS; Poosti F; Dam W; Navis G; van Goor H; van den Born J
Dis Model Mech; 2015 Aug; 8(8):919-30. PubMed ID: 26035383
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
Remuzzi A; Puntorieri S; Battaglia C; Bertani T; Remuzzi G
J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
[TBL] [Abstract][Full Text] [Related]
15. A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats.
Wang JL; Cheng HF; Shappell S; Harris RC
Kidney Int; 2000 Jun; 57(6):2334-42. PubMed ID: 10844603
[TBL] [Abstract][Full Text] [Related]
16. Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature.
Adamczak M; Gross ML; Amann K; Ritz E
J Am Soc Nephrol; 2004 Dec; 15(12):3063-72. PubMed ID: 15579509
[TBL] [Abstract][Full Text] [Related]
17. The potential role of perivascular lymphatic vessels in preservation of kidney allograft function.
Tsuchimoto A; Nakano T; Hasegawa S; Masutani K; Matsukuma Y; Eriguchi M; Nagata M; Nishiki T; Kitada H; Tanaka M; Kitazono T; Tsuruya K
Clin Exp Nephrol; 2017 Aug; 21(4):721-731. PubMed ID: 27770292
[TBL] [Abstract][Full Text] [Related]
18. Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation.
Ots M; Mackenzie HS; Troy JL; Rennke HG; Brenner BM
J Am Soc Nephrol; 1998 Feb; 9(2):224-30. PubMed ID: 9527398
[TBL] [Abstract][Full Text] [Related]
19. Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition.
Macconi D; Sangalli F; Bonomelli M; Conti S; Condorelli L; Gagliardini E; Remuzzi G; Remuzzi A
Am J Pathol; 2009 Mar; 174(3):797-807. PubMed ID: 19164508
[TBL] [Abstract][Full Text] [Related]
20. Proteinuria triggers renal lymphangiogenesis prior to the development of interstitial fibrosis.
Yazdani S; Poosti F; Kramer AB; Mirković K; Kwakernaak AJ; Hovingh M; Slagman MC; Sjollema KA; de Borst MH; Navis G; van Goor H; van den Born J
PLoS One; 2012; 7(11):e50209. PubMed ID: 23189189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
